Cancer

New survey shows most Canadians overlook their liver health, yet 1 in 4 is affected by liver disease

TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Only nine per cent of Canadians prioritize their liver when thinking about their…

11 months ago

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a…

11 months ago

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry…

11 months ago

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs…

11 months ago

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

CHICAGO, IL / ACCESS Newswire / January 21, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a…

11 months ago

Healthcare Analytics Industry to Hit USD 133.1 billion by 2029 with 24.3% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 21, 2025 /PRNewswire/ -- Despite the economic uncertainties, healthcare analytics companies have demonstrated strong resilience throughout…

11 months ago

Oshi Health Adds to Recent $60 Million Funding with Strategic Investments from American College of Gastroenterology, American Gastroenterological Association and Practicing Physicians with Scrub Capital

Clinical leadership coalition highlights importance of multidisciplinary hybrid care and supports Oshi's expansion as the only virtual GI center of…

11 months ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company…

11 months ago

Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters…

11 months ago

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…

11 months ago